Year: 2026

BURLINGTON, Mass., March 04, 2026 (GLOBE NEWSWIRE) — Aware, Inc. (NASDAQ: AWRE), a global leader in biometric identity and authentication solutions, today reported financial results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter 2025 and Recent Operational HighlightsExpanded federal and commercial engagement with the deployment of Aware’s first mobile biometric solution within a U.S. federal agency and continued growth across international government programs.Expanded partner relationships through integrations with digital workflow providers and a partnership with a biometric hardware vendor. These efforts are intended to support Aware’s broader go-to-market strategy over time.Strengthened Aware’s industry leadership and core biometric technology through multiple independent validations,...

GUELPH, Ontario, March 04, 2026 (GLOBE NEWSWIRE) — Linamar Corporation (TSX: LNR) Continued Strong Free Cash Flow and Liquidity$937.2 million of Free Cash Flow1 generated in 2025, up $148.9 million from the prior year due to careful cash management, resulting in the 13th consecutive year of positive Free Cash Flow and the second highest in Linamar’s history; and Liquidity1 is strong at $2.1 billion, up $216.9 million or 11.8% from Q4 2024.Outstanding Earnings Performance from Our Diversified StrategyRecord Normalized Net Earnings1 achieved for second consecutive year at $622.1 million despite moderately lower sales at $10.2 billion; Normalized Earnings per Share1 has increased 25.3% to $2.28 for the quarter and 5.6% to an annual record of $10.36 for 2025; and 2025 marks 13 out of 16 years of earnings growth at Linamar; consistent...

SCYNEXIS received a one-time non-refundable payment in Q4 2025 totalling $24.8 million from GSKSCYNEXIS announced dosing of the first patient using the intravenous (IV) formulation of SCY-247 in a Phase 1 study and plans to report topline data in the second half of 2026  Responding to patients’ need for alternatives to existing anti-fungal therapies, SCYNEXIS plans to initiate an expanded access program for SCY-247 in the first half of 2026SCYNEXIS ended Q4 2025 with cash, cash equivalents and investments of $56.3 million, resulting in a cash runway of more than two yearsJERSEY CITY, N.J., March 04, 2026 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today reported financial results for the...

Dallas, Texas, March 04, 2026 (GLOBE NEWSWIRE) — CompX International Inc. (NYSE American: CIX) announced today net sales of $37.7 million for the fourth quarter of 2025 compared to $38.4 million in the same period of 2024. Operating income was $5.6 million in the fourth quarter of 2025 compared to $4.9 million in the same period of 2024. Net income was $4.7 million, or $.38 per basic and diluted common share, for the fourth quarter of 2025 compared to $4.5 million, or $.37 per basic and diluted common share, in the same period of 2024. Net sales for the year ended December 31, 2025 were $158.3 million compared to $145.9 million in the previous year. Operating income was $22.6 million for the year ended December 31, 2025 compared to $17.0 million in 2024. Net income for the year ended December 31, 2025 was $19.5 million, or $1.58...

Castellum, Inc. Announces 2025 Unaudited Financial ResultsCastellum, Inc. (NYSE-American: CTM), announces certain unaudited highlights of its operating results for its year ended December 31, 2025 – www.castellumus.comVIENNA, Va., March 04, 2026 (GLOBE NEWSWIRE) — Castellum, Inc. (“Castellum” “CTM”, “we” or the “Company”) (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services company focused on the federal government, announces certain unaudited highlights of its operating results for its year ended December 31, 2025. Revenue for 2025 increased to $52.9 million, representing an $8.1 million (15.2%) increase over $44.8 million in 2024. Operating loss improved to $2.8 million, a $4.4 million year-over-year improvement from an operating loss of $7.2 million in 2024. Net loss to common shareholders...

NN delivers third consecutive year of successful transformation; completes majority of heavy spending NN forecasts fourth year of improvement, and a return to organic net sales growth in 2026 CHARLOTTE, N.C., March 04, 2026 (GLOBE NEWSWIRE) — NN, Inc. (NASDAQ: NNBR) (“NN” or the “Company”), a global diversified industrial company that engineers and manufactures high-precision components and assemblies, today reported its financial results for the fourth quarter and full-year ended December 31, 2025. Key results include: Financial HighlightsQ4 2025 net sales of $104.7 million and full-year 2025 net sales $422.2 million Q4 2025 gross margin of 9.2% and full-year 2025 gross margin of 14.1% Q4 2025 adjusted gross margin of approximately 18.8%, up 120 bps and approaching the Company’s five-year target of 20% Q4 2025 operating...

REDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) — Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth quarter and full year ended December 31, 2025. Recent HighlightsDelivered $90.5 million in worldwide revenue for the full year of 2025, an 8% increase over the prior year and an increase of 7% on a constant currency basis Achieved worldwide revenue of $22.6 million for the fourth quarter of 2025, a 5% decrease over the same period last year and a decrease of 7% on a constant currency basis Realized gross margin of 78% in the fourth quarter of 2025 and 74% for the full year of 2025 Refinanced existing debt, securing up to $60 million in committed capital under a new 5-year interest-only...

Demonstrates 99.9% two-qubit gate fidelity at 28 nanosecond gate speed on prototype platform BERKELEY, Calif., March 04, 2026 (GLOBE NEWSWIRE) — Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced its financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter and Full-Year 2025 Financial HighlightsTotal revenues for the three months ended December 31, 2025 were $1.9 million Operating loss for the three months ended December 31, 2025 was $22.6 million For the three months ended December 31, 2025: GAAP net loss $18.2 million; non-GAAP net loss $11.3 million For the three months ended December 31, 2025: GAAP net loss per share $(0.06); non-GAAP net loss per share $(0.03) For the year ended December 31, 2025: Total...

Fourth Quarter Revenue Increased 20% to a Record $23.4 Million Full Year 2025 Revenue Increased 20% to $90.3 Million, Generating GAAP EPS of $0.91 BOCA RATON, Fla., March 04, 2026 (GLOBE NEWSWIRE) — Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced financial results for the fourth quarter and full year ended December 31, 2025. “We concluded 2025 with record fourth quarter results, capping a year defined by disciplined execution and continued momentum across the enterprise,” stated Derek Dubner, red violet’s CEO. “Our cloud-native architecture, embedded artificial intelligence, and extensive longitudinal identity graph continue to differentiate us in the marketplace, particularly in regulated and mission-critical environments. The durability and scalability of our model are...

MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today reported financial results for the fourth quarter and full year ended December 31, 2025 and initiated financial guidance for full year 2026.   Recent Financial HighlightsGenerated fourth quarter 2025 total revenue of $20.4 million, an increase of 7% compared to the same period in the prior year, and full year 2025 total revenue of $77.4 million, a decrease of 3% compared to full year 2024. Achieved total gross margin of 87% in the fourth quarter of 2025 compared to 87% in the same period in the prior year,...